Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
111C-flumazenil
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206 💬
211C]flumazenil
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
31500mg mesalazine pellets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
418F-RO6958948----3件: 5, 7, 127 💬
5250mg mesalazine pellets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
6500mg mesalazine pellets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
7750mg mesalazine pellets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
8[18F]flumazenil
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206 💬
9ACT-050089 (Ro 61-0612)----1件: 86 💬
10Azathioprine OR Mesalazine
(Rowasa (TN))		2件: Azathioprine,
Mesalazine (Rowasa)		2件: Azathioprine ,
Mesalamine (Rowasa (TN)) 💬		--1件: 96 💬
11Benznidazole
(Rochagan (TN))		1件: Benznidazole1件: Benznidazole (Rochagan (TN)) 💬--1件: 65 💬
12BMS-986089-01 (RO7239361) , anti-myostatin----1件: 113 💬
13BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
14BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
15BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
16BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
17BMS-986089-01 (RO7239361), anti-myostatin----1件: 113 💬
18Butyrate enemas + routine management1件: Butyric Acid---1件: 291 💬
19C5 inh MAb, SKY59, RO/CH7092230----2件: 62, 109 💬
20Calcitriol
(Rocaltrol (TN))		1件: Calcitriol (Rocaltrol)1件: Calcitriol (Rocaltrol (TN)) 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 18, 37, 46, 49, 66, 96, 158, 235, 326 💬
21Calcitriol & Calcium
(Rocaltrol (TN))		2件: Calcitriol (Rocaltrol),
Calcium (Rocky Mountain Multiple Vit and Min Mega Tab)		1件: Calcitriol (Rocaltrol (TN)) 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 235 💬
22Calcium rosuvastatin2件: Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
23Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--2件: 96, 97 💬
24Crestor Tablets (calcium rosuvastatin) Film-Coated tablets2件: Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
25Delayed and extended release mesalazine
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
26Delayed Release 6MP or Calcitriol vs. Purinethol
(Rocaltrol (TN))		1件: Calcitriol (Rocaltrol)1件: Calcitriol (Rocaltrol (TN)) 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
27Dexmedetomidine with ropivacaine2件: Dexmedetomidine,
Ropivacaine		2件: Dexmedetomidine ,
Ropivacaine 💬		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
28Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole		2件: Pramipexole ,
Dopamine 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
29Emicizumab (ACE910, RO5534262)1件: Emicizumab1件: Emicizumab 💬2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288 💬
30EU-approved RoActemra1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
31Evérolimus----1件: 34 💬
32Flumazenil
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
33Gamma-secretase/Notch signalling pathway inhibitor RO4929097----1件: 74 💬
34GDC-0853 RO7010939----3件: 13, 46, 49 💬
35GLYCYRRHIZA GLABRA ROOT1件: Glycyrrhiza glabra (Glycyrrhiza Glabra Root Powder)---1件: 97 💬
36Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)1件: Reynoutria multiflora root---1件: 6 💬
37HP-3000 (ropinirole hydrochloride patch)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
38HP-3000(ropinirole hydrochloride patch)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
39Humira 40 mg injekcní roztok v predplnené injekcní stríkacce1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
40HYDROCORTISONE ROUSSEL1件: Hydrocortisone (Soothe Rodan Fields)1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
41IDEC-C2B8, Ro 45-2294----1件: 64 💬
42IgG IL2/RO7049665----1件: 95 💬
43Interferon Alfa-2A
(Roferon A (TN))		2件: Interferon alfa,
Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)		2件: Interferon alfa-2a (Roferon A (TN)),
Interferon alfa 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
44LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
45LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
46LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
47LY03003(Rotigotine,extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
48Magnesium with ropivacaine2件: Magnesium (Rocky Mountain Multiple Vit and Min Mega Tab),
Ropivacaine		1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
49Mesalazine
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--3件: 46, 96, 97 💬
50Mesalazine (3,600 mg)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
51Mesalazine (Asacol®)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
52Mesalazine (Mesalamine)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 96 💬
53Mesalazine - TID 1000 mg
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
54Mesalazine - TID 2x 500 mg
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
55Mesalazine 1000 mg gastro-resistant tablets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
56Mesalazine 250Mg
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
57Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
(Rowasa (TN))		2件: Mesalazine (Rowasa),
Nitazoxanide		2件: Mesalamine (Rowasa (TN)),
Nitazoxanide 💬		--1件: 97 💬
58Mesalazine 4G Enema
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
59Mesalazine 500 mg gastro-resistant tablets (Salofa
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
60Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
61Mesalazine EC 500 mg
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 96 💬
62Mesalazine Enema
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
63Mesalazine liquid enema
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
64Mesalazine slow-release granules
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
65Mesalazine Sustained-Release Tablets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 96 💬
66Mesalazine tablet
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
67Mesalazine tablets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 96 💬
68Mesalazine with hydrocortisone sodium succinate
(Rowasa (TN))		2件: Hydrocortisone (Soothe Rodan Fields),
Mesalazine (Rowasa)		2件: Hydrocortisone ,
Mesalamine (Rowasa (TN)) 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
69Mesalazine, Tripterygium glycosides
(Rowasa (TN))		2件: Mesalazine (Rowasa),
Tripterygium wilfordii whole		1件: Mesalamine (Rowasa (TN)) 💬--1件: 96 💬
70MINOXIDIL
(Rogaine (TN))		1件: Minoxidil (Mens rogaine Minoxidil - Unscented Formula)1件: Minoxidil (Rogaine (TN)) 💬2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 179 💬
71MMX mesalamine/ mesalazine
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
72MMX Mesalamine/Mesalazine
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
73MMX Mesalamine/Mesalazine (High Dose)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
74MMX Mesalamine/Mesalazine (Low Dose)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
75Ocrelizumab (Roche, Switzerland)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
76Oral roflumilast1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299 💬
77Overencapsulated mesalazine tablets
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
78PET with 11C-Flumazenil
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
79Pramipexole or ropinirole2件: Pramipexole,
Ropinirole		2件: Pramipexole ,
Ropinirole 💬		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
80PRO145223 (RO5490261)----1件: 97 💬
81PZN 8881655(RochePharma AG)----1件: 85 💬
82R-roscovitine1件: Seliciclib (R-roscovitine)---1件: 75 💬
83RAD001 round tablets----1件: 158 💬
84Ramelteon
(Rozerem (TN))		1件: Ramelteon (Rozerem)1件: Ramelteon (Rozerem (TN)) 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46 💬
85Rapamycin-calcitriol combination
(Rocaltrol (TN))		2件: Calcitriol (Rocaltrol),
Sirolimus		2件: Calcitriol (Rocaltrol (TN)),
Sirolimus 💬		2件: MTOR,
VDR 💬		55件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
86Recombinant human growth hormone + rosiglitazone2件: Rosiglitazone,
Somatotropin		1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
87Riluzole Oral Soluble film (ROSF) 50 mg1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
88RO----1件: 6 💬
89Ro 001-9265----1件: 41 💬
90Ro 001-9265/F02----1件: 41 💬
91RO 001-9265/F02-01----1件: 46 💬
92Ro 001-9265/F03----1件: 41 💬
93Ro 001-9265/F04----1件: 41 💬
94Ro 002-9893/F02----1件: 46 💬
95Ro 106-1443----1件: 49 💬
96Ro 45-2294----1件: 46 💬
97Ro 47-0203----4件: 51, 85, 86, 88 💬
98Ro 47-0203 / ACT-050088----1件: 86 💬
99Ro 48-77533----1件: 46 💬
100Ro 487-533/F01----1件: 271 💬
101Ro 487-5733/F01----1件: 271 💬
102RO 487-7533----1件: 46 💬
103Ro 487-7533/F01----3件: 46, 107, 271 💬
104Ro 487-7533/F10----2件: 46, 107 💬
105Ro 487-7533/F10-02----1件: 46 💬
106Ro 487-7533/F10-04----4件: 41, 46, 51, 107 💬
107Ro 491-7523/F18----1件: 206 💬
108Ro 491-7523/F19----1件: 206 💬
109RO 496-4913----2件: 46, 49 💬
110Ro 496-4913/F03----2件: 13, 46 💬
111Ro 496-4913/F07----1件: 13 💬
112Ro 533-3787/F01- 06----1件: 13 💬
113Ro 533-3787/F01-06----1件: 11 💬
114Ro 549-0261/F04----1件: 97 💬
115Ro 549-0261/F04-02----1件: 96 💬
116Ro 549-0261/F08-02----1件: 96 💬
117RO 551-6922----1件: 46 💬
118Ro 723-4292/F02----1件: 8 💬
119Ro Actemra1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
120Ro-47-0203----1件: 86 💬
121Ro-47-0203/029----1件: 86 💬
122RO-496-4913----1件: 46 💬
123Ro-Actemra1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
124RO001-9265/F04----1件: 46 💬
125RO0029893----1件: 46 💬
126RO0220912----1件: 85 💬
127RO0280296----1件: 85 💬
128RO045-2294----1件: 46 💬
129RO0452294/V01----2件: 43, 44 💬
130RO0452294/V02----3件: 35, 43, 44 💬
131RO0485337----1件: 222 💬
132RO04877533----1件: 46 💬
133RO04877533/F05/F04----1件: 46 💬
134RO0506997----2件: 13, 46 💬
135Ro106-1443----1件: 43 💬
136RO1061443/F02----1件: 35 💬
137RO3300074----1件: 231 💬
138RO4402257----1件: 46 💬
139Ro45-2294----1件: 271 💬
140RO452294/V02----1件: 46 💬
141Ro47-0203----1件: 86 💬
142Ro47-0203 / ACT-050088----2件: 51, 86 💬
143Ro487-7533----1件: 46 💬
144RO487-7533/F01-F05----1件: 46 💬
145RO487-7533/F10-04----2件: 46, 51 💬
146RO4877533----2件: 46, 107 💬
147RO4877533 (TCZ)----2件: 46, 107 💬
148RO4877533/F01----1件: 46 💬
149RO4877533/F04-F05----1件: 46 💬
150RO4917523----1件: 206 💬
151RO4917523 0.5 mg----1件: 206 💬
152RO4917523 1.5 mg----1件: 206 💬
153RO496-4913----1件: 46 💬
154RO4964913----1件: 13 💬
155RO4964913 F07----1件: 13 💬
156RO4964913/F03----1件: 13 💬
157RO4964913/F07----1件: 13 💬
158RO4964913/F07-01----1件: 13 💬
159RO5072759----1件: 222 💬
160RO5333787----2件: 11, 13 💬
161RO545-9072/F03----1件: 53 💬
162RO5459072----1件: 53 💬
163Ro549-0261/F04-02----1件: 96 💬
164RO5490255----1件: 85 💬
165RO5490255/F01-02----1件: 85 💬
166RO5490261 / F02----1件: 97 💬
167RO5490261/F02----1件: 97 💬
168RO5490261/F04-02----1件: 97 💬
169RO5534262 EMICIZUMAB1件: Emicizumab1件: Emicizumab 💬2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288 💬
170RO6885247----1件: 3 💬
171RO6885247/F02----1件: 3 💬
172RO6885247/F03----1件: 3 💬
173RO7010939----2件: 13, 46 💬
174RO7010939/F13----1件: 49 💬
175RO7021610----1件: 97 💬
176RO7034067----1件: 3 💬
177RO7034067 / F12----1件: 3 💬
178RO7034067 / F13----1件: 3 💬
179RO7034067/F06 + solvente (RO----1件: 3 💬
180RO7034067/F06 with solvent (RO7034067/F08)----1件: 3 💬
181RO7034067/F07 + solvente (RO----1件: 3 💬
182RO7034067/F07 with solvent (RO7034067/F09)----1件: 3 💬
183RO7034067/F12----1件: 3 💬
184RO7034067/F13----1件: 3 💬
185RO7046015----1件: 6 💬
186RO7046015/PRASINEZUMAB1件: Prasinezumab1件: Prasinezumab 💬1件: SNCA 💬3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6 💬
187RO7049665----2件: 95, 97 💬
188RO7049665/IgG-IL2/ IgG-IL2ND2----1件: 95 💬
189RO7090919----1件: 3 💬
190RO7112689----1件: 62 💬
191RO7112689/F01----1件: 62 💬
192RO7112689/F03-01----2件: 62, 109 💬
193RO7112689/F03-10----2件: 62, 109 💬
194RO7121932----1件: 13 💬
195RO7123520----1件: 46 💬
196RO7123520/F03-01----1件: 46 💬
197RO7204239----2件: 3, 113 💬
198RO7204239/F01-01----1件: 3 💬
199RO7234292----1件: 8 💬
200RO7234292 (RG6042)----1件: 8 💬
201RO7239361----1件: 113 💬
202RO7239361 (BMS-986089)----1件: 113 💬
203RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
204RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
205RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
206RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
207RO7246311----1件: 97 💬
208RO7248824----1件: 201 💬
209RO7248824/F02-01----1件: 201 💬
210RO7248824/F03-01 (Diluent for RO7248824/F02-01----1件: 201 💬
211RO7303509----1件: 51 💬
212RO7490677----1件: 85 💬
213RO7490677 160 mg/8 ml----1件: 85 💬
214RO7490677 160 mg/8mL----1件: 85 💬
215RO7490677 160mg/8mL----1件: 85 💬
216RO7490677 320 mg/16 ml (2nd generation)----1件: 85 💬
217RO7490677 320mg/16mL (1st generation)----1件: 85 💬
218RO7490677 320mg/16mL (2nd generation)----1件: 85 💬
219RO7490677/ F01-02----1件: 85 💬
220RO7490677/F01-01----1件: 85 💬
221RO7490677/F01-02----1件: 85 💬
222RO7490677/F01-03----1件: 85 💬
223RoActemra1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬11件: 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 💬
224RoActemra (R)1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
225ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
226ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
227RoActemra 162 mg1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
228RoActemra 162 mg solution for injection in pre-filled syringe1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
229RoActemra 162 mg solution injectable en seringue préremplie1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
230RoActemra 162 mg soluzione iniettabile in siringa preriempita1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 50 💬
231RoActemra 20 mg/ml concentrado para solución para perfusión1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
232RoActemra 20 mg/ml Concentrate for solution for infusion1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
233RoActemra 20 mg/ml concentrate for solution for infusion.1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
234ROACTEMRA 20 mg/ml, concentrado para solución para perfusión1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 46, 107, 271 💬
235RoActemra 20mg/ml1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 40 💬
236RoActemra(R)1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
237RoActemra/Actemra (tocilizumab)1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107 💬
238RoActemra®1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 271 💬
239RoActemra® 20mg/ml Konzentrat1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
240RoActemra®EV Product Code: PRD823211件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
241RoActerma----1件: 46 💬
242RoActmera----1件: 46 💬
243Rob 803----1件: 46 💬
244Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali----1件: 46 💬
245Rob 803 (capsules 12.5 mg)----1件: 46 💬
246Rob 803 (capsules 15 mg)----1件: 46 💬
247Rob 803 (capsules 25 mg)----1件: 46 💬
248Rob 803 (capsules 6.25 mg)----1件: 46 💬
249Rob 803 12.5mg capsule----1件: 46 💬
250Rob 803 15mg capsule----1件: 46 💬
251Rob 803 25mg capsule----1件: 46 💬
252Rob 803 6.25mg capsule----1件: 46 💬
253Rob 803 6.5mg capsule----1件: 46 💬
254Rocuronium1件: Rocuronium---2件: 70, 296 💬
255Rocuronium Bromide1件: Rocuronium---1件: 70 💬
256Rodatristat ethyl----1件: 86 💬
257Rodatristat ethyl 300 mg tablet BID----1件: 86 💬
258Rodatristat ethyl 600 mg BID----1件: 86 💬
259Rofecoxib1件: Rofecoxib1件: Rofecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
260Roferon-A1件: Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)1件: Interferon alfa-2a (Roferon A (TN)) 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
261Roferon-A 3miu1件: Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)1件: Interferon alfa-2a (Roferon A (TN)) 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
262Roferon-A, 3miu1件: Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)1件: Interferon alfa-2a (Roferon A (TN)) 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
263Roferon-A, 4.5miu1件: Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)1件: Interferon alfa-2a (Roferon A (TN)) 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
264Roferon-A, 6miu1件: Interferon alfa-2a (Roferon A Sterile Pws 18m Unit/vial)1件: Interferon alfa-2a (Roferon A (TN)) 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
265Roflumilast1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬4件: 84, 97, 206, 299 💬
266Roflumilast 500 Ug ORAL TABLET [Daliresp]1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 97 💬
267Roflumilast Oral Tablet1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299 💬
268Rokan (r) Novo 120 mg----1件: 18 💬
269Rolipram1件: Rolipram1件: Rolipram 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13 💬
270Romiplostim1件: Romiplostim1件: Romiplostim 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
271Romiplostim plus dexamethasone2件: Dexamethasone (Ropidex),
Romiplostim		2件: Dexamethasone ,
Romiplostim 💬		2件: MPL,
NR3C1 💬		3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
272Romiplostin----1件: 63 💬
273ROMOSOZUMAB1件: Romosozumab1件: Romosozumab 💬1件: SOST 💬2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬1件: 274 💬
274Rontalizumab1件: Rontalizumab1件: Rontalizumab 💬13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
275ROP----1件: 6 💬
276ROP+L-Dopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
277ROPINIROLE1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 309 💬
278Ropinirole (as hydrochloride)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
279Ropinirole controlled-release (REQUIP CR) for RLS1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
280Ropinirole CR 2mg tablet1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
281Ropinirole CR 8mg tablet1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
282Ropinirole Hydrochloride1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309 💬
283Ropinirole hydrochloride extended-release tablet1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
284Ropinirole hydrochloride extended-release tablet placebo1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
285Ropinirole hydrochloride prolonged release2件: Manganese citrate,
Ropinirole		1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
286Ropinirole immediate release1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
287Ropinirole Implant1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
288Ropinirole IR1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
289Ropinirole IR Tablets1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
290Ropinirole monotherapy1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
291Ropinirole oral product1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
292Ropinirole PR1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
293Ropinirole PR, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
294Ropinirole PR/XR1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
295Ropinirole PR/XR Tablets1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
296Ropinirole Prolonged release1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
297Ropinirole prolonged release/extended release(PR/XR)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
298Ropinirole XL1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
299Ropinirole XL (formerly CR)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
300Ropinirole/L-dopa2件: Levodopa,
Ropinirole		2件: Levodopa ,
Ropinirole 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
301Ropivacaine1件: Ropivacaine1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬4件: 22, 36, 46, 70 💬
302Ropivacaine Hydrochloride Injection1件: Ropivacaine1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
303Ropivacaine plus normal saline1件: Ropivacaine1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
304Roscovitine----1件: 299 💬
305Rosiglitazone1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265 💬
306Rosiglitazone (Avandia)1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 222 💬
307Rosiglitazone Extended Release Tablets1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 46 💬
308Rosiglitazone maleate1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265 💬
309Rosiglitazone XR1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 46 💬
310Rosuvastatin1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
311Rosuvastatin 10 mg1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 96 💬
312Rosuvastatin 10mg1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 97 💬
313Rosuvastatin 20mg1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
314ROSUVASTATIN CALCIUM2件: Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬4件: 49, 79, 97, 299 💬
315Rosuvastatin calcium 40mg2件: Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 56 💬
316Rosuvastatine EG----1件: 97 💬
317ROT-TDS 8 mg/24 h----1件: 6 💬
318Rotigotin----1件: 6 💬
319ROTIGOTINA1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
320ROTIGOTINE1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
321Rotigotine (Reference product PR 2.1.1)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
322Rotigotine (Test product PR 2.3.1)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
323Rotigotine hydrochloride1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
324Rotigotine Nasal Spray1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
325Rotigotine transdermal patch1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
326Rotigotine transdermal patch 2mg/24h(10cm2)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
327Rotigotine transdermal patch 4mg/24h (20cm2)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
328Rotigotine transdermal patch 6mg/24h (30cm2)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
329Rotigotine transdermal patch 8mg/24h (40cm2)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
330Rotigotine TTS (Test)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
331Rotigotine, extended-release microspheres1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
332Routine steroid administration group----1件: 85 💬
333Routine transdermal oestrogen patch----1件: 78 💬
334Routine Treatment of CD----1件: 96 💬
335Roxithromycin1件: Roxithromycin1件: Roxithromycin 💬--2件: 46, 299 💬
336Royal jelly1件: Royal jelly1件: Royal jelly 💬--1件: 49 💬
337ROZANOLIXIZUMAB1件: Rozanolixizumab1件: Rozanolixizumab 💬1件: FCGRT 💬-3件: 11, 14, 63 💬
338ROZEREM1件: Ramelteon (Rozerem)1件: Ramelteon (Rozerem (TN)) 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
339Rozibafusp Alfa----1件: 49 💬
340Satralizumab (RO5333787/Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
341Satralizumab (RO5333787/Enspryng/SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
342Satralizumab (RO5333787/SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
343Satrazlizumab (RO5333787/ Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
344Selective Nerve Root Block----1件: 70 💬
345SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE----1件: 166 💬
346Solution de chlorhydrate de dopamine anaérobie1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
347SPD476 (mesalazine)
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
348SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
(Rowasa (TN))		1件: Mesalazine (Rowasa)1件: Mesalamine (Rowasa (TN)) 💬--1件: 97 💬
349Standardized turmeric root extract1件: Turmeric (Kua Domestica Root)---1件: 299 💬
350Tocilizumab (Actemra or RoActemra)1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
351Tocilizumab [RoActemra/Actemra]1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬4件: 46, 51, 107, 331 💬
352Tocilizumab [RoActemra]1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
353Tocilizumab Infusion RoAcemtra (EU)1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
354Tocilizumab Roche1件: Tocilizumab (Roactemra)1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
355Tolicizumab Roche----1件: 46 💬
356Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)----1件: 6 💬
357Tramadol with ropivacaine2件: Ropivacaine,
Tramadol		2件: Ropivacaine ,
Tramadol 💬		6件: OPRM1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		6件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction 💬1件: 70 💬
358Transdermal flumazenil (Added 4/2020)
(Romazicon (TN))		1件: Flumazenil (Romazicon)1件: Flumazenil (Romazicon (TN)) 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
359Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
360Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
361UTTR1147A/RO7021610 (Active)----2件: 96, 97 💬